Gut microbiota-mediated berberine metabolism ameliorates cholestatic liver disease by suppressing 5-hydroxytryptamine productionDianji Tu, Shiming Yang, Yusong Ge et al.|Clinical and Molecular Hepatology|2025Cited by 6